Hypertensive patients with carotid artery plaque exhibit increased platelet aggregability

Thrombosis Research

Volumn 117, Issue 6, 2006, Pages 615-622

  Fusegawa, Yuichi ^a   Hashizume, Hiromi ^a   Okumura, Toshiaki ^a   Deguchi, Yoshiaki ^b   Shina, Yutaka ^b   Ikari, Yuji ^b   Tanabe, Teruhisa ^b  

^a Sagamidai Hospital   (Japan)

^b School of Medicine   (Japan)

Author keywords

Carotid artery plaque; Hypertension; Platelet aggregation

Indexed keywords

ADRENALIN; CHOLESTEROL; FIBRINOGEN; GLUCOSE; HEMOGLOBIN A1C; LIPOPROTEIN; TRIACYLGLYCEROL;

ADRENALIN BLOOD LEVEL; ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; BODY MASS; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION COEFFICIENT; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT;

ADENOSINE DIPHOSPHATE; AGED; ARTERIOSCLEROSIS; CAROTID ARTERIES; CAROTID STENOSIS; CASE-CONTROL STUDIES; EPINEPHRINE; FEMALE; HUMANS; HYPERTENSION; LASERS; LIGHT; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET COUNT; SCATTERING, RADIATION;

EID: 33646052552     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2005.05.011     Document Type: Article

References (36)

1. Thaulow E., Erikssen J., Sandvik L., Stormorken H., and Cohn P.F. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 84 (1995) 613-617
2. Miyamoto S., Kawano H., Sakamoto T., Soejima H., Kajiwara I., Shimomura H., et al. Formation of platelet microaggregates correlates with adverse clinical outcome in patients with coronary artery disease. Thromb Haemost 89 4 (2003 (Apr.)) 681-686
3. Willoughby S., Holmes A., and Loscalzo J. Platelets and cardiovascular disease. Eur J Cardiovasc Nurs 1 4 (2002 (Dec.)) 273-288
4. Gebara O.C., Jimenez A.H., McKenna C., Mittleman M.A., Xu P., Lipinska I., et al. Stress-induced hemodynamic and hemostatic changes in patients with systemic hypertension: effect of verapamil. Clin Cardiol 19 3 (1996 (Mar.)) 205-211
5. Somova L., and Mufunda J. Platelet activity and salt sensitivity in the pathogenesis of systemic (essential) hypertension in black Africans. Clin Exp Hypertens 15 5 (1993 (Sep.)) 781-796
6. Nomura E., Kohriyama T., Yamaguchi S., Kajikawa H., and Nakamura S. Association between carotid atherosclerosis and hemostatic markers in patients with cerebral small artery disease. Blood Coagul Fibrinolysis 9 1 (1998 (Jan.)) 55-62
7. Doruk H., Kaptan K., Saglam M., Ateskan U., Beyan C., Nevruz O., et al. The relationship between carotid atherosclerosis and platelet aggregation in elderly. Arch Gerontol Geriatr 37 3 (2003 (Nov.-Dec.)) 235-239
8. Miyamoto S., Sakamoto T., Soejima H., Shimomura H., Kajiwara I., Kojima S., et al. Plasma thioredoxin levels and platelet aggregability in patients with acute myocardial infarction. Am Heart J 146 3 (2003 (Sep.)) 465-471
9. Miyamoto S., Kawano H., Sakamoto T., Soejima H., Kajiwara I., Shimomura H., et al. Formation of platelet microaggregates correlates with adverse clinical outcome in patients with coronary artery disease. Thromb Haemost 89 4 (2003 (Apr.)) 681-686
10. Eto K., Takeshita S., Ochiai M., Ozaki Y., Sato T., and Isshiki T. Platelet aggregation in acute coronary syndromes: use of a new aggregometer with laser light scattering to assess platelet aggregability. Cardiovasc Res 40 1 (1998 (Oct.)) 223-229
11. Miyamoto S., Ogawa H., Soejima H., Takazoe K., Kajiwara I., Sakamoto T., et al. Increased rate of formation of small-sized platelet aggregates in patients with acute coronary syndromes. Jpn Circ J 64 9 (2000 (Sep.)) 647-652
12. Tanaka M., Kawahito K., Adachi H., and Ino T. Platelet dysfunction in acute type A aortic dissection evaluated by the laser light-scattering method. J Thorac Cardiovasc Surg 126 3 (2003 (Sep)) 837-841
13. Ozaki Y., Satoh K., Yatomi Y., Shirasawa Y., and Kume S. Detection of platelet aggregates with a particle counting method using light scattering. Anal Biochem 218 2 (1994) 284-294
14. Fusegawa Y., Goto S., Handa S., Kawada T., and Ando Y. Platelet spontaneous aggregation in platelet-rich plasma is increased in habitual smokers. Thromb Res 93 6 (1999) 271-278
15. Fusegawa Y., and Handa S. Platelet aggregation induced by ADP or epinephrine is enhanced in habitual smokers. Thromb Res 97 5 (2000) 287-295
16. Salonen R., Seppanen K., Rauramaa R., and Salonen J.T. Prevalence of carotid atherosclerosis and serum cholesterol levels in eastern Finland. Arteriosclerosis 8 6 (1988 (Nov.-Dec.)) 788-792
17. Born G.V. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194 (1962 (Jun. 9)) 927-929
18. Yamagami H., Kitagawa K., Nagai Y., Hougaku H., Sakaguchi M., Kuwabara K., et al. Higher levels of interleukin-6 are associated with lower echogenicity of carotid artery plaques. Stroke 35 3 (2004) 677-681
19. Metso S., Loimaala A., Mercuri M.F., Nenonen A., Vuori Oja P., Bond M.G., et al. Circulating oxidized low-density lipoprotein and common carotid artery intima-media thickness a random sample of middle-aged men. J Biomed Sci 11 3 (2004) 356-361
20. Fox C.S., Larson M.G., Corey D., Feng D., Lindpaintner K., Polak J.F., et al. Absence of association between polymorphisms in the hemostatic factor pathway genes and carotid intimal medial thickness: Framingham Heart Study. Stroke 35 3 (2004) e65-e67
21. Ferroni P., Basili S., Farco A., and Davi G. Platelet activation in type 2 diabetes mellitus. J Thromb Haemost 2 8 (2004 (Aug.)) 1282-1291
22. Vericel E., Januel C., Carreras M., Moulin P., and Lagarde M. Diabetic patients without vascular complications display enhanced basal platelet activation and decreased antioxidant status. Diabetes 53 4 (2004 (Apr.)) 1046-1051
23. Fukuda K., Ozaki Y., Satoh K., Kume S., Tawata M., Onaya T., et al. Phosphorylation of myosin light chain in resting platelets from NIDDM patients is enhanced: correlation with spontaneous aggregation. Diabetes 46 3 (1997 (Mar.)) 488-493
24. Sakamoto T., Ogawa H., Kawano H., Hirai N., Miyamoto S., Takazoe K., et al. Rapid change of platelet aggregability in acute hyperglycemia. Detection by a novel laser-light scattering method. Thromb Haemost 83 3 (2000 (Mar.)) 475-479
25. Coleman Jr. L.G., Polanowska-Grabowska R.K., Marcinkiewicz M., and Gear AR. LDL oxidized by hypochlorous acid causes irreversible platelet aggregation when combined with low levels of ADP, thrombin, epinephrine, or macrophage-derived chemokine (CCL22). Blood 104 2 (2004 (Jul. 15)) 380-389 [Electronic publication 2004 Mar. 30]
26. Osamah H., Mira R., Sorina S., Shlomo K., and Michael A. Reduced platelet aggregation after fluvastatin therapy is associated with altered platelet lipid composition and drug binding to the platelets. Br J Clin Pharmacol 44 1 (1997 (Jul.)) 77-83
27. Pirich C., Schmid P., Fitscha P., Wytek R., O Grady J., and Sinzinger H. Influence of calcium antagonists on platelet function and vascular prostacyclin production. Blood Press Suppl 1 (1994) 75-80
28. Kalinowski L., Matys T., Chabielska E., Buczko W., and Malinski T. Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release. Hypertension 40 4 (2002 (Oct.)) 521-527
29. Ozaki Y., Yatomi Y., and Kume S. Effects of oral hypoglycaemic agents on platelet functions. Biochem Pharmacol 44 4 (1992 (Aug. 18)) 687-691
30. Florkowski C.M., Richardson M.R., Le Guen C., Jennings P.E., O'Donnell M.J., Jones A.F., et al. Effect of gliclazide on thromboxane B2, parameters of haemostasis, fluorescent IgG and lipid peroxides in non-insulin dependent diabetes mellitus. Diabetes Res 9 2 (1988 (Oct.)) 87-90
31. Waysbort J., Regitz G., Chaimowitz D., Tuval M., Nakash I., and Brunner D. Effects of glibenclamide on serum lipids, lipoproteins, thromboxane, beta-thromboglobulin, and prostacyclin in non-insulin-dependent diabetes mellitus. Clin Ther 10 4 (1988) 358-371
32. Milani M., Cimminiello C., Lorena M., Arpaia G., Soncini M., and Bonfardeci G. Effects of two different HMG-CoA reductase inhibitors on thromboxane production in type IIA hypercholesterolemia. Biomed Pharmacother 50 6-7 (1996) 269-274
33. Akdemir R., Ozhan H., Yazici M., Gunduz H., Duran S., Gurel C., et al. In vivo effect of losartan on platelet aggregation in patients with hypertension. Heart Vessels 19 4 (2004 (Jul.)) 167-171
34. Larkins R.G., Jerums G., Taft J.L., Godfrey H., Smith I.L., and Martin T.J. Lack of effect of gliclazide on platelet aggregation in insulin-treated and non-insulin-treated diabetes: a two-year controlled study. Diabetes Res Clin Pract 4 2 (1988 (Jan.)) 781-787
35. Igawa T., Nagamura Y., Ozeki Y., Itoh H., and Unemi F. Stenosis enhances role of platelets in growth of regional thrombus and intimal wall thickening in carotid arteries. Circ Res 77 2 (1995) 310-316
36. de Lorgeril M., Boissonnat P., Mamelle N., Martin J.L., Monjaud I., Guidollet J., et al. Platelet aggregation and HDL cholesterol are predictive of acute coronary events in heart transplant recipients. Circulation 89 6 (1994) 1590-1594